Karimi-Shahri, Mehdi, Javid, Hossein, Sharbaf Mashhad, Alireza, Yazdani, Shaghayegh, Hashemy, Seyed Isaac. (1400). Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend. , 24(10), 1307-1323. doi: 10.22038/ijbms.2021.58227.12934
Mehdi Karimi-Shahri; Hossein Javid; Alireza Sharbaf Mashhad; Shaghayegh Yazdani; Seyed Isaac Hashemy. "Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend". , 24, 10, 1400, 1307-1323. doi: 10.22038/ijbms.2021.58227.12934
Karimi-Shahri, Mehdi, Javid, Hossein, Sharbaf Mashhad, Alireza, Yazdani, Shaghayegh, Hashemy, Seyed Isaac. (1400). 'Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend', , 24(10), pp. 1307-1323. doi: 10.22038/ijbms.2021.58227.12934
Karimi-Shahri, Mehdi, Javid, Hossein, Sharbaf Mashhad, Alireza, Yazdani, Shaghayegh, Hashemy, Seyed Isaac. Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend. , 1400; 24(10): 1307-1323. doi: 10.22038/ijbms.2021.58227.12934

Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend

Iranian Journal of Basic Medical Sciences
دوره 24، شماره 10، دی 2021، صفحه 1307-1323    اصل مقاله (935.95 K)
نوع مقاله: Review Article
شناسه دیجیتال (DOI): 10.22038/ijbms.2021.58227.12934
نویسندگان
Mehdi Karimi-Shahri1، 2؛ Hossein Javid3، 4؛ Alireza Sharbaf Mashhad5؛ Shaghayegh Yazdani6؛ Seyed Isaac Hashemy* 4، 7
1Department of Pathology, School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran
2Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran
4Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of ‎Medical Sciences, Mashhad, Iran
5Department of Medical Laboratory Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
6Department of Medical Laboratory Sciences, Ilam Institute for Medical Sciences, Ilam, Iran
7Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
چکیده
For a long time, mesenchymal stem cells (MSCs) were discussed only as stem cells which could give rise to different types of cells. However, when it became clear that their presence in the tumor microenvironment (TME) was like a green light for tumorigenesis, they emerged from the ashes. This review was arranged to provide a comprehensive and precise description of MSCs’ role in regulating tumorigenesis and to discuss the dark and the bright sides of cancer treatment strategies using MSCs.
To gather the details about MSCs, we made an intensive literature review using keywords, including MSCs, tumor microenvironment, tumorigenesis, and targeted therapy. Through transferring cytokines, growth factors, and microRNAs, MSCs maintain the cancer stem cell population, increase angiogenesis, provide a facility for cancer metastasis, and shut down the anti-tumor activity of the immune system. Although MSCs progress tumorigenesis, there is a consensus that these cells could be used as a vehicle to transfer anti-cancer agents into the tumor milieu. This feature opened a new chapter in MSCs biology, this time from the therapeutic perspective. Although the data are not sufficient, the advent of new genetic engineering methods might make it possible to engage these cells as Trojan horses to eliminate the malignant population. So many years of investigation showed that MSCs are an important group of cells, residing in the TME, studying the function of which not only could add a delicate series of information to the process of tumorigenesis but also could revolutionize cancer treatment strategies.
کلیدواژه‌ها
Carcinogenesis؛ Mesenchymal stem cells؛ Molecular targeted therapies؛ Neoplasm Tumor microenvironment
مراجع
آمار
تعداد مشاهده مقاله: 1,512
تعداد دریافت فایل اصل مقاله: 1,006
دانشگاه علوم پزشکی مشهد
آمار
تعداد نشریات29
تعداد شماره‌ها2,324
تعداد مقالات24,861
تعداد مشاهده مقاله82,768,046
تعداد دریافت فایل اصل مقاله45,833,822
اخبار نشریات